NMRA
Neumora Therapeutics, Inc.
0.5962$
-12.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | +116.9% | -0.7% | +16.4% | -36.1% | -39.7% | |
| – | – | +114.4% | -6.7% | +23.3% | -34.3% | -39.3% | |
| – | – | +113.2% | -41.1% | +55.2% | -62.0% | +28.4% | |
| – | – | +113.2% | -9.1% | +22.1% | -32.2% | -40.7% | |
| – | – | +35.1% | +359.5% | +2.2% | – | – | |
| – | – | – | -60.0% | – | – | – | |
| – | – | +3.0% | +163.4% | – | – | – | |
| – | +1,391,947.6% | +158.1% | +15.7% | -96.9% | +10.3% | +191.5% | |
| – | +44,519.0% | +148.4% | +1.8% | +6.0% | +19.0% | +8.6% | |
| – | – | +38.2% | +219.1% | +0.2% | -45.1% | -84.7% | |
| – | – | -31.7% | +336.1% | -95.3% | +881.3% | +2.2% | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | -38.8% | -63.8% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +4.5% | +0.3% | +2.5% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.